Pharming Group N.V. - ADR
XNAS:PHAR
| Market Cap (Intraday) | 1.25B |
| Current PE | 1,169.40 |
| Forward PE | 1798 |
| 2yr Forward PE | N/A |
| 10-Day MA | $17.22 |
| 50-Day MA | $15.42 |
| 200-Day MA | $11.90 |
Pharming Group N.V. - ADR Stock, XNAS:PHAR
Vondellaan 47, Leiden, Zuid-Holland 2332 AA
Netherlands
Phone: +31.71.524.74.00
Number of Employees:
Description
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST�®, Joenja�®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.